All News

In a case that serves as a cautionary tale of the consequences of lax health data security, HHS announced that wireless health services provider CardioNet has agreed to pay $2.5 million after its insufficient data protection led to personal health information being stolen.

A study evaluating a patient-reported outcomes measure tool in patients who had undergone colorectal surgery recommends using the tool for preoperative counseling prior to surgery.

The FDA announced yesterday it had issued warning letters to 14 companies peddling a total of over 65 products falsely claiming to cure or treat cancer. The agency’s forceful stance seemed intended to raise awareness among vulnerable consumers as well as discourage other potential instances of fraud.

Will bundled payments be implemented quickly or slowly? Will they be voluntary or mandatory? There's disagreement about what the ongoing movement toward accountable care should look like.

A new report published by the Urban Institute suggests that CMS’ Oncology Care Model could be substantially improved by incorporating a formal framework for shared decision making between patients and oncologists.

Research over the past decade has found connections between poor sleep and obesity, but this is the first study to examine the connections among bedtimes in young children, emotional self-regulation, and obesity later in life.

Eli Lilly and Company has announced that abemaciclib improved progression-free survival (PFS) when combined with an aromatase inhibitor (AI), compared with AI alone, in patients with breast cancer.

A study published in Cancer Medicine shows that rates of gallbladder cancer have been declining since the 1970s among men, but not for women. It also found that late-stage cases of the cancer have become increasingly common.

The suit comes after Mylan has already faced hearing in Congress and investigations from the US Department of Justice and the Federal Trade Commission.

The 2017 National Health Security Preparedness Index, released by the Robert Wood Johnson Foundation, indicates that the United States is slowly becoming more prepared to handle public health catastrophes, but some states are still lagging behind.

A study in Journal of Medical Internet Research sought to discover how technologies could encourage daily walking in this population. The researchers developed 3 prototype apps using different persuasive technology design principles: dialogue support, primary task support, and social support.

The most common modifiable behavioral risk factors identified in the study are all treatable, suggesting that prevention could go a long way toward reducing their impact.

The University of Connecticut has initiated recruitment for a phase I trial to test the safety and efficacy of OncoImmunome, a personalized vaccine designed to prevent relapse in patients diagnosed with Stage III or IV ovarian cancer.

A second biosimilar to infliximab, marketed as Remicade by Johnson & Johnson, has received FDA approval. Infliximab-abda (Renflexis) was developed by Samsung Bioepis/Merck and has been approved for multiple indications.

A new study published in JAMA Internal Medicine finds that adding Medicare fee schedules to hospitals’ electronic health record systems did not significantly impact the number of laboratory tests ordered by physicians.

A new predictive model that relies primarily on patient demographics was able to improve predictive accuracy of identifying high-cost patients in the future at Intermountain Healthcare. The results of the study and the specifics of the model were published in >eGEMs.

The compromise to align interests of the conservative Freedom Caucus and the moderate Tuesday Group would give governors and state legislatures the final say on whether to remove essential health benefits or create a high-risk pool for those with expensive chronic conditions.

A new study finds that the prevalence of diabetes is significantly higher among non-obese Filipino Americans aged 50 and older than in their white counterparts, even after controlling for lifestyle factors.

At this year’s meeting, themed Fueling the Cancer Moonshot, attendees will gain a better understanding of strategies for success within the community oncology realm.

This week, the top managed care stories included a new rule from CMS to end abuse on the Affordable Care Act insurance exchanges; a study that indicates type 2 diabetes may possibly be reversed; and CareMore unveils a new care model that takes place in the dentist's chair.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

The authors found great variation in wellness visits by location, along with socioeconomic disparities.

Although the purpose of eligibility criteria is to protect patients from unnecessary harm, define the study population, and allow researchers to collect safety and efficacy data for a specific population, unnecessary restriction may not capture the heterogeneity of real-world patients.

Standard biomarker tests miss many patients who develop kidney failure. Also, many patients who are not at high risk end up in clinical trials, adding expense when they will not help researchers prove anything.

The approval of the Paxman Scalp Cooling System follows a randomized clinical trial, whose results were published in JAMA following an interim analysis.

A new study investigating the link between state medical marijuana laws and Medicaid prescription drug spending has found that states with such laws had lower prescribing rates in 5 of 9 clinical areas examined.